Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Net Income: 2021-2025

Historic Net Income for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to -$8.0 million.

  • MDxHealth's Net Income rose 23.68% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.1 million, marking a year-over-year increase of 24.70%. This contributed to the annual value of -$38.1 million for FY2024, which is 11.67% up from last year.
  • Per MDxHealth's latest filing, its Net Income stood at -$8.0 million for Q3 2025, which was down 8.82% from -$7.4 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Net Income ranged from a high of -$6.7 million in Q4 2024 and a low of -$18.1 billion during Q2 2022.
  • In the last 3 years, MDxHealth's Net Income had a median value of -$10.0 million in 2023 and averaged -$9.5 million.
  • The largest annual percentage gain for MDxHealth's Net Income in the last 5 years was 99.94% (2023), contrasted with its biggest fall of 41.58% (2023).
  • MDxHealth's Net Income (MRQ) stood at -$20.9 million in 2021, then soared by 41.77% to -$12.2 million in 2022, then grew by 12.02% to -$10.7 million in 2023, then surged by 37.07% to -$6.7 million in 2024, then dropped by 18.93% to -$8.0 million in 2025.
  • Its last three reported values are -$8.0 million in Q3 2025, -$7.4 million for Q2 2025, and -$8.9 million during Q1 2025.